Validation of the european SCORE risk chart in the healthy middle-aged Japanese.

[1]  G. Collins,et al.  Prediction models for cardiovascular disease risk in the general population: systematic review , 2016, British Medical Journal.

[2]  D. Panagiotakos,et al.  Validation of the HellenicSCORE (a Calibration of the ESC SCORE Project) Regarding 10-Year Risk of Fatal Cardiovascular Disease in Greece. , 2015, Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese.

[3]  Olga V. Demler,et al.  Tests of calibration and goodness‐of‐fit in the survival setting , 2015, Statistics in medicine.

[4]  Andrew E Moran,et al.  Demographic and epidemiologic drivers of global cardiovascular mortality. , 2015, The New England journal of medicine.

[5]  T. Ohkubo,et al.  Risk of hypercholesterolemia for cardiovascular disease and the population attributable fraction in a 24-year Japanese cohort study. , 2015, Journal of atherosclerosis and thrombosis.

[6]  P. Jose,et al.  Cardiovascular disease mortality in Asian Americans. , 2014, Journal of the American College of Cardiology.

[7]  T. Ohkubo,et al.  Cumulative impact of axial, structural, and repolarization ECG findings on long-term cardiovascular mortality among healthy individuals in Japan: National Integrated Project for Prospective Observation of Non-Communicable Disease and its Trends in the Aged, 1980 and 1990 , 2014, European journal of preventive cardiology.

[8]  M. Woodward,et al.  A cardiovascular disease policy model that predicts life expectancy taking into account socioeconomic deprivation , 2014, Heart.

[9]  Dmitri A. Jdanov,et al.  Recalibration of the SCORE risk chart for the Russian population , 2014, European Journal of Epidemiology.

[10]  Jennifer G. Robinson,et al.  2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, Circulation.

[11]  Andy H. Lee,et al.  Cardiovascular disease risk score prediction models for women and its applicability to Asians , 2014, International journal of women's health.

[12]  Andy H. Lee,et al.  Utility of established cardiovascular disease risk score models for the 10-year prediction of disease outcomes in women , 2013, Expert review of cardiovascular therapy.

[13]  P. Royston,et al.  External validation of a Cox prognostic model: principles and methods , 2013, BMC Medical Research Methodology.

[14]  T. Ohkubo,et al.  Long-term risk of BP values above normal for cardiovascular mortality: a 24-year observation of Japanese aged 30 to 92 years , 2012, Journal of hypertension.

[15]  Shah Ebrahim,et al.  European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (Version 2012) , 2012, International Journal of Behavioral Medicine.

[16]  A. Briggs,et al.  Effectiveness and cost effectiveness of cardiovascular disease prevention in whole populations: modelling study , 2011, BMJ : British Medical Journal.

[17]  L. Shaw,et al.  Comparison of Framingham, PROCAM, SCORE, and Diamond Forrester to predict coronary atherosclerosis and cardiovascular events , 2011, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[18]  P. Kolh,et al.  ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). , 2011, European heart journal.

[19]  F. Buitrago,et al.  Performance of the Framingham and SCORE cardiovascular risk prediction functions in a non-diabetic population of a Spanish health care centre: a validation study , 2010, Scandinavian journal of primary health care.

[20]  Maria Giné-Garriga,et al.  Therapeutic implications of selecting the SCORE (European) versus the D'AGOSTINO (American) risk charts for cardiovascular risk assessment in hypertensive patients , 2009, BMC cardiovascular disorders.

[21]  K. Yamagishi,et al.  Trends for blood pressure and its contribution to stroke incidence in the middle-aged Japanese population: the Circulatory Risk in Communities Study (CIRCS). , 2009, Stroke.

[22]  Makoto Watanabe,et al.  Cardiovascular Disease and Risk Factors in Asia: A Selected Review , 2008, Circulation.

[23]  M. Dyakova,et al.  Cardiovascular risk assessment of Bulgarian urban population: cross-sectional study. , 2008, Croatian medical journal.

[24]  L. Kuller,et al.  Marine-derived n-3 fatty acids and atherosclerosis in Japanese, Japanese-American, and white men: a cross-sectional study. , 2008, Journal of the American College of Cardiology.

[25]  Christos Lionis,et al.  Implementing the European guidelines for cardiovascular disease prevention in the primary care setting in Cyprus: Lessons learned from a health care services study , 2008, BMC health services research.

[26]  H. Ueshima.  Explanation for the Japanese paradox: prevention of increase in coronary heart disease and reduction in stroke. , 2007, Journal of atherosclerosis and thrombosis.

[27]  Shah Ebrahim,et al.  European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invit , 2007, European heart journal.

[28]  Shah Ebrahim,et al.  Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts) , 2007 .

[29]  M. Woodward,et al.  Cardiovascular risk prediction tools for populations in Asia , 2007, Journal of Epidemiology and Community Health.

[30]  Shinichi Sato,et al.  Improvement in Japanese clinical laboratory measurements of total cholesterol and HDL-cholesterol by the US Cholesterol Reference Method Laboratory Network. , 2003, Journal of atherosclerosis and thrombosis.

[31]  H. Tunstall-Pedoe,et al.  Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. , 2003, European heart journal.

[32]  Anthony Rodgers,et al.  Effectiveness and costs of interventions to lower systolic blood pressure and cholesterol: a global and regional analysis on reduction of cardiovascular-disease risk , 2003, The Lancet.

[33]  A. Döring,et al.  Classical risk factors and their impact on incident non-fatal and fatal myocardial infarction and all-cause mortality in southern Germany. Results from the MONICA Augsburg cohort study 1984-1992. Monitoring Trends and Determinants in Cardiovascular Diseases. , 1998, European heart journal.

[34]  D Kromhout,et al.  Serum total cholesterol and long-term coronary heart disease mortality in different cultures. Twenty-five-year follow-up of the seven countries study. , 1995, JAMA.

[35]  I. BalaguerVintró,et al.  Multifactorial prevention of ischemic cardiopathy. Experiment on coronary risk factors in an industrial population. Results of the first 2 years , 1981 .

[36]  F. Cambien,et al.  CORONARY HEART DISEASE IN MIDDLE-AGED FRENCHMEN Comparisons between Paris Prospective Study, Seven Countries Study, and Pooling Project , 1980, The Lancet.

[37]  Lippincott Williams Wilkins.  XVII. The Diet , 1970 .

[38]  S. Sans,et al.  Recruitment methods and differences in early, late and non-respondents in the first MONICA-Catalonia population survey. , 1990, Revue d'epidemiologie et de sante publique.

[39]  M. Kornitzer,et al.  Regional differences in dietary habits, coronary risk factors and mortality rates in Belgium: Design and methodology , 1984 .

[40]  J. Gerrard,et al.  Letter: Sex-linked mental retardation. , 1974, Lancet.